Liya Su

1.8k total citations · 1 hit paper
65 papers, 1.4k citations indexed

About

Liya Su is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Liya Su has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in Liya Su's work include Mycobacterium research and diagnosis (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Pharmacological Effects of Natural Compounds (7 papers). Liya Su is often cited by papers focused on Mycobacterium research and diagnosis (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Pharmacological Effects of Natural Compounds (7 papers). Liya Su collaborates with scholars based in China, United States and Spain. Liya Su's co-authors include Robert J. Greenstein, Sheldon T. Brown, Guangliang Huang, Ming Kuang, Tongyi Huang, Baoxian Liu, Jieyi Ye, Ming Xu, Bowen Zhuang and Chunyang Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Liya Su

62 papers receiving 1.4k citations

Hit Papers

Supramolecular Photothermal Nanomedicine Mediated Distant... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liya Su China 17 426 282 223 201 162 65 1.4k
Jin Hu China 22 489 1.1× 206 0.7× 86 0.4× 110 0.5× 78 0.5× 42 1.4k
Krzysztof Piotr Bielawski Poland 26 781 1.8× 318 1.1× 146 0.7× 212 1.1× 176 1.1× 109 2.1k
Lu Dai China 31 1.2k 2.9× 399 1.4× 126 0.6× 45 0.2× 180 1.1× 138 2.6k
Zhilong Wang China 23 549 1.3× 65 0.2× 238 1.1× 81 0.4× 79 0.5× 63 1.7k
Eduard Post Netherlands 20 419 1.0× 290 1.0× 42 0.2× 199 1.0× 98 0.6× 38 1.2k
Feng Ji China 25 1.1k 2.6× 272 1.0× 39 0.2× 88 0.4× 118 0.7× 106 2.2k
Haifeng Wang China 22 785 1.8× 161 0.6× 45 0.2× 45 0.2× 146 0.9× 115 2.2k
Kamel Besseghir Switzerland 21 434 1.0× 193 0.7× 102 0.5× 174 0.9× 72 0.4× 34 1.3k
Prem N. Gupta India 37 1.5k 3.5× 179 0.6× 97 0.4× 54 0.3× 149 0.9× 94 3.5k

Countries citing papers authored by Liya Su

Since Specialization
Citations

This map shows the geographic impact of Liya Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liya Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liya Su more than expected).

Fields of papers citing papers by Liya Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liya Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liya Su. The network helps show where Liya Su may publish in the future.

Co-authorship network of co-authors of Liya Su

This figure shows the co-authorship network connecting the top 25 collaborators of Liya Su. A scholar is included among the top collaborators of Liya Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liya Su. Liya Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Liya, Timothy J. Purwin, Sophia Ran, et al.. (2025). Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti–PD-1 Therapy in NRAS-Mutant Melanoma. Journal of Investigative Dermatology. 145(10). 2549–2561.e11. 3 indexed citations
2.
Xu, Hongwei, Yuting Feng, Yiming Han, et al.. (2024). Bacterial–host adhesion dominated by collagen subtypes remodelled by osmotic pressure. npj Biofilms and Microbiomes. 10(1). 124–124. 1 indexed citations
3.
Wang, Mengqi, Wenqi Zhang, Qin Jin, et al.. (2024). Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression. International Journal of Nanomedicine. Volume 19. 1985–2004. 13 indexed citations
4.
Zhao, Kai, Yu Du, Huimin Cao, et al.. (2024). The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering. Colloids and Surfaces B Biointerfaces. 247. 114435–114435. 6 indexed citations
5.
Wei, Ying, et al.. (2024). Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms. Frontiers in Pharmacology. 15. 1377592–1377592. 8 indexed citations
6.
Lü, Yan, et al.. (2024). PWP1 is overexpressed in hepatocellular carcinoma and facilitates liver cancer cell proliferation. Heliyon. 10(11). e32409–e32409. 1 indexed citations
7.
Zhang, Wenqi, Fang-Yuan Liu, Shubin Li, et al.. (2023). Alleviative Effect of Lactoferrin Interventions Against the Hepatotoxicity Induced by Titanium Dioxide Nanoparticles. Biological Trace Element Research. 202(2). 624–642. 12 indexed citations
8.
Zhong, Xian, Lili Chen, Liya Su, et al.. (2022). The “stiff rim” sign of hepatocellular carcinoma on shear wave elastography: correlation with pathological features and potential prognostic value. Abdominal Radiology. 47(12). 4115–4125. 2 indexed citations
9.
Cao, Chen, Devin Kwok, Qing Li, et al.. (2021). Disentangling genetic feature selection and aggregation in transcriptome-wide association studies. Genetics. 220(2). 19 indexed citations
10.
Tong, Xin, Xianjue Wang, Xiaoyu Yang, et al.. (2021). ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway. Biomedicine & Pharmacotherapy. 137. 111209–111209. 11 indexed citations
11.
Liu, Baoxian, Guangliang Huang, Xiaohua Xie, et al.. (2020). Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience. International Journal of Hyperthermia. 37(1). 1202–1209. 6 indexed citations
13.
Cai, Weijia, Liya Su, Lili Liao, et al.. (2019). PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth. Nature Communications. 10(1). 5800–5800. 55 indexed citations
14.
Greenstein, Robert J., et al.. (2018). Failure to detect M. avium subspecies paratuberculosis in Johne’s disease using a proprietary fluorescent in situ hybridization assay. BMC Research Notes. 11(1). 498–498. 1 indexed citations
15.
Su, Liya, et al.. (2015). Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway. Acta Pharmacologica Sinica. 36(12). 1514–1519. 33 indexed citations
17.
Greenstein, Robert J., Liya Su, & Sheldon T. Brown. (2010). The Thioamides Methimazole and Thiourea Inhibit Growth of M. avium Subspecies paratuberculosis in Culture. PLoS ONE. 5(6). e11099–e11099. 8 indexed citations
18.
Greenstein, Robert J., Liya Su, & Sheldon T. Brown. (2009). On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture. International Journal of Infectious Diseases. 13(5). e254–e263. 9 indexed citations
19.
Greenstein, Robert J., Liya Su, Robert H. Whitlock, & Sheldon T. Brown. (2009). Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture. Gut Pathogens. 1(1). 4–4. 12 indexed citations
20.
Ye, Linbai, Shengli Zhu, Hong Zheng, et al.. (2008). The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation. Biochemical and Biophysical Research Communications. 369(2). 287–291. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026